Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Humulin 70/30 Kwikpen - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Humulin 70/30 Kwikpen

Approved

STANDARD

Humulin 70/30 Kwikpen

Lilly France(Fegersheim)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 1d9a6bc1ff846e02
Company: Lilly France(Fegersheim)
Type: Standard

Approval Details

Approval Id: 1d9a6bc1ff846e02
Drug Approval Philippines Name: Humulin 70/30 Kwikpen
Product Name: Humulin 70/30 Kwikpen
Registration Number: BR-950
Brand Name: Humulin 70/30 Kwikpen
Generic Name: Insulin Human (rDNA)
Dosage Form: Suspension For Injection (S.C.)
Dosage Strength: 100 IU/mL
Manufacturer: Lilly France(Fegersheim)
Importer: Zuelling Pharma Corporation
Distributor: Zuelling Pharma Corporation
Issuance Date: 24 January 2024
Expiry Date: 27 May 2029
Pharmacologic Category: Antidiabetics
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1d9a6bc1ff846e02

Type

Standard

Back to Philippines FDA Approvals